Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
amplimed.com

See what CB Insights has to offer

Board of Directors

2

AmpliMed Board of Directors

2 Board of directors

AmpliMed has 2 board of directors, including Harry George.

Name

Firm

Work History

Other Seats

Harry George

AdiCyte, Carefx, Connected Corporation, HTG Molecular Diagnostics, Interleaf, Lumidigm, Medipacs, Sequencia Corporation, SynCardia Systems, and WEGO Systems

John Holliman

John M. Holliman, III has served as Executive Chairman and Principal Executive Officer of the Company since April 2006 and has served as a director of the Company since September 1987 and as Chairman of the Board of Directors since August 1997. Since February 1993 he has been a general partner of entities which are the general partners of Valley Ventures, LP (formerly known as Arizona Growth Partners, LP), Valley Ventures II, LP, Valley Ventures III, LP, Valley Ventures III Annex, LP, all of which are venture capital funds that invest principally in life science companies. Mr. Holliman, III has over thirty years of business experience, including service on the boards of over forty companies, commercial lending experience with major financial institutions, and has been active in venture capital financing for over twenty-five years, concentrating in the medical/biotech industries. Mr. Holliman earned a BBA in Finance and a MBA from Southern Methodist University and a Master of International Management from the Thunderbird School of Global Management. During his career Mr. Holliman has gained substantial executive and board level experience in business, finance and operations.

Autonet Mobile, and HTG Molecular Diagnostics

Name

Harry George

John Holliman

Firm

Work History

John M. Holliman, III has served as Executive Chairman and Principal Executive Officer of the Company since April 2006 and has served as a director of the Company since September 1987 and as Chairman of the Board of Directors since August 1997. Since February 1993 he has been a general partner of entities which are the general partners of Valley Ventures, LP (formerly known as Arizona Growth Partners, LP), Valley Ventures II, LP, Valley Ventures III, LP, Valley Ventures III Annex, LP, all of which are venture capital funds that invest principally in life science companies. Mr. Holliman, III has over thirty years of business experience, including service on the boards of over forty companies, commercial lending experience with major financial institutions, and has been active in venture capital financing for over twenty-five years, concentrating in the medical/biotech industries. Mr. Holliman earned a BBA in Finance and a MBA from Southern Methodist University and a Master of International Management from the Thunderbird School of Global Management. During his career Mr. Holliman has gained substantial executive and board level experience in business, finance and operations.

Other Seats

AdiCyte, Carefx, Connected Corporation, HTG Molecular Diagnostics, Interleaf, Lumidigm, Medipacs, Sequencia Corporation, SynCardia Systems, and WEGO Systems

Autonet Mobile, and HTG Molecular Diagnostics

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.